Pancreatic Cancer Research

ResearcherKarolinska University HospitalNo recent work listed

Maria Liljefors

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7914-2372; OpenAlex author ID A5007643473. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia - A comparison with pancreatic ductal ad… Co-author DOI 10.1016/j.pan.2022.04.007↗
  2. Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer. Last author DOI 10.1371/journal.pone.0169736↗
  3. A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer. Last author DOI 10.1371/journal.pone.0121197↗
  4. Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients. Last author DOI 10.3892/ijo.2014.2496↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximilian Kordes · 1 shared paper, 2022 · strength 0.17
  2. Marcus Holmberg · 1 shared paper, 2022 · strength 0.17
  3. Ernesto Sparrelid · 1 shared paper, 2022 · strength 0.17
  4. Stefan Linder · 1 shared paper, 2022 · strength 0.17
  5. Poya Ghorbani · 1 shared paper, 2022 · strength 0.17
  6. Matthias J. Löhr · 1 shared paper, 2022 · strength 0.17
  7. Gustav Jörgen Ullenhag · 2 shared papers, 2015–2017 · strength 0.17
  8. Håkan Mellstedt · 2 shared papers, 2014–2017 · strength 0.14
  9. Caroline Staff · 1 shared paper, 2014 · strength 0.06
  10. Jan‐Erik Frödin · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.